Buy N-dimethyltryptamine Cas 4761-32-4

Buy N-dimethyltryptamine Cas 4761-32-4

α,N,N-Trimethyltryptamine (α,N,N-TMT, α-TMT, or ATMT), also known as α-methyl-N,N-dimethyltryptamine (α-methyl-DMT or α-Me-DMT) or as Alpha-N, is a psychedelic drug of the tryptamine and α-alkyltryptamine families.^[2][3] It is similar in chemical structure to other psychedelic tryptamines such as N,N-dimethyltryptamine (DMT) and α-methyltryptamine (αMT).^[3] It is taken orally.^[1]

α,N,N-TMT was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved), but he did not mention having tested it and did not describe its effects, dose, or duration.^[2] In 2025, Hamilton Morris described having synthesized and assayed α,N,N-TMT.^[1] He reported that it was an active psychedelic taken orally but was much less potent than AMT.^[1]

The drug has been tested in animals and compared with α-methyltryptamine (αMT).^[3] It was found to produce similar effects as αMT, such as hyperlocomotion and reversal of reserpine-induced behavioral depression, but with only around half the potency of αMT.^[3]

Analogues of α,N,N-TMT (N,N-dimethyl-AMT) include α-methyltryptamine (AMT), α,N-DMT (N-methyl-AMT), α-methylserotonin (AMS; 5-HO-AMT), 5-MeO-AMT (α,O-DMS), α,N,O-TMS (N-methyl-5-MeO-AMT), and α,N,N,O-TeMS (N,N-dimethyl-5-MeO-AMT), among others.^[2]

α,N,N-TMT was encountered as a novel designer drug in Europe by 2015.^[4]

α,N,N-TMT is not an explicitly nor implicitly controlled substance in Canada as of 2025.^[5]

α,N,N-TMT is not an explicitly controlled substance in the United States.^[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.